WHO Adds Two New Vaccines to Ebola Trial in DR Congo
- Published:
- First detected:
Insights by Echo AI
The World Health Organization (WHO) has recommended adding two new vaccine candidates to the ongoing Ebola trial in the Democratic Republic of Congo (DRC). The vaccines, ChAdOx1 BDBV and mRNA-1469, are specifically designed to protect against the Bundibugyo virus, which is responsible for the current outbreak. This marks the first time vaccines targeting this specific Ebola strain will be evaluated during an epidemic. The trial, led by the National Institute of Biomedical Research of DRC, aims to determine the efficacy of these vaccines against the Bundibugyo virus.
Source coverage
11
records merged
1
1 unique
0
0 unique
10
9 unique
11 Sources
OMS recomenda testes clínicos de duas novas vacinas para cepa do Ebola...
WHO says 2 new candidate vaccines to join Ebola trial in DR Congo ChAd...
#DRC | The WHO has recommended adding two experimental vaccines to Ebo...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
